1
Schmidt Gunter Dr, Brandes Arndt Dr, Angerbauer Rolf Dr, Loegers Michael Dr, Mueller Gliemann Matthias Dr, Schmeck Carsten Dr, Bremm Klaus Dieter Dr, Bischoff Hilmar Dr, Schmidt Delf Dr, Schuhmacher Joachim Dr, Giera Henry Dr, Paulsen Holger Dr, Naab Paul Dr, Conrad Michael Dr, Stoltefuss Juergen: Cycloalkano-pyridine as cetp inhibitors. Bayer, January 14, 1998: EP0818448-A1 (95 worldwide citation)

Cycloalkano-pyridine compounds of formula (I) and their salts and N-oxides are new. A = 6-10C aryl (optionally up to penta-substituted by halo, NO2, OH, CF3, OCF3, 1-7C alkyl, 1-7C acyl, 1-7C hydroxyalkyl, 1-7C alkoxy or NR3R4); R3, R4 = H, phenyl or 1-6C alkyl; D = 6-10C aryl (optionally substitute ...


2
Stoltefuss Juergen D I, Boeshagen Horst Dr, Goldmann Siegfried Dr, Straub Alexander Dr, Gross Rainer Prof Dr, Huetter Joachim Dr, Hebisch Siegbert Dr, Bechem Martin Dr: 4-quinolyl-dihydropyridines, process for their prepatation and their use in medicaments.. Bayer, October 23, 1991: EP0452712-A1 (27 worldwide citation)

Compounds of the general formula I in which R and R are identical or different and represent straight-chain or branched alkyl having up to 8 carbon atoms, R represents nitro or cyano, or R and R together form a lactone ring of the formula R represents a radical of the formula in which R denotes hydr ...


3
Boeshagen Horst Dr, Stoltefuss Juergen Dipl Ing, Berschauer Friedrich Dr, de Jong Anno Dr, Scheer Martin Dr, Horstmann Harald Dr, Seidle Peter Rudolf Dr: Phenylethylemine derivatires as growth stimulators.. Bayer, March 28, 1984: EP0103830-A2 (18 worldwide citation)

Phenylethylamine derivatives of the formula I in which the radicals R, R2, R3, R4, X, Y and Z are as defined in the description, and their use as growth-stimulating additives in animal nutrition.


4
Stoltefuss Juergen Dipl Ing, Goldmann Siegfried Dr, Straub Alexander Dr, Boeshagen Horst Dr, Bechem Martin Dr, Gross Rainer Prof Dr, Hebisch Siegbert Dr, Huetter Joachim Dr, Rounding Howard Paul Dr: New 2-amino-5-cyano-1,4-dihydropyridines, process for their preparation and use in pharmaceutical compositions.. Bayer, December 2, 1992: EP0515940-A1 (15 worldwide citation)

Die vorliegende Erfindung betrifft neue 2-Amino-5-cyano-4-chinolin-1,4-dihydropyridine der allgemeinen Formel I in welcher R, R und R die in der Beschreibung angegebene Bedeutung haben, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln, insbesondere in Mitteln zur Behandlung von He ...


5
Stoltefuss Juergen Dipl Ing, Goldmann Siegfried Dr, Straub Alexander Dr, Bechem Martin Dr, Gross Rainer Prof Dr, Hebisch Siegbert Dr, Huetter Joachim Dr, Rounding Howard Paul: 3-quinolyl substituted dihydropyridines, process for their preparation and their use in drugs.. Bayer, December 7, 1994: EP0627427-A1 (11 worldwide citation)

The invention relates to new 3-quinolyl-substituted dihydropyridines of the general formula (I) in which R1 to R5 have the meaning given in the description, process for their preparation and their use in drugs, in particular in compositions for the treatment of cardiovascular disorders.


6
Stoltefuss Juergen D I, Goldmann Siegfried Dr, Straub Alexander Dr, Gross Rainer Prof Dr, Bechem Martin Dr, Hebisch Siegbert Dr, Huetter Joachim Dr, Rounding Howard Paul Dr: Arylquinoline substituted 1,4-dihydropyridine dicarboxylic derivatives, process for their preparation and their use as drugs.. Bayer, April 28, 1993: EP0538690-A1 (11 worldwide citation)

Die Erfindung betrifft neue Aryl-Chinolyl-substituierte 1,4-Dihydropyridin-dicarbonsäurederivate der allgemeinen Formel I in welcher R bis R und X die in der Beschreibung angegebene Bedeutung haben, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln, insbesondere zur Herstellung in ...


7
Stoltefuss Juergen Dipl Ing, Goldmann Siegfried Dr, Straub Alexander Dr, Bechem Martin Dr, Gross Rainer Prof Dr, Hebisch Siegbert Dr, Huetter Joachim Dr, Rounding Howard Paul Dr: 2-amino-4-quinoline-dihydropyridine, process for preparation and use thereof.. Bayer, November 2, 1994: EP0622369-A2 (11 worldwide citation)

The present invention relates to 2-amino-4-quinoline-1,4-dihydropyridines of the general formula (I) in which R1 to R4 have the meaning given in the description, a process for their preparation and their use in medicaments, in particular in compositions for the treatment of cardiovascular disorders.


8
Straub Alexander Dr, Goldmann Siegfried Dr, Stoltefuss Juergen Dipl Ing, Bechem Martin Dr S, Dembrowsky Klaus Dr, Gross Rainer Prof Dr, Hebisch Siegbert Dr, Huetter Joachim Dr, Rounding Howard Paul Dr: 4-bicyclic substituted dihydropyridines, process for their preparation and their use in medicaments.. Bayer, December 28, 1994: EP0630895-A1 (9 worldwide citation)

The invention relates to novel 4-bicyclic-substituted dihydropyridines of the general formula (I) in which R1 to R5 have the meaning given in the description, a process for their preparation and their use in medicaments, in particular in compositions for the treatment of cardiovascular disorders.


9
Stoltefuss Juergen Dipl Ing, Franckowiak Gerhard Dr, Boeshagen Horst Dr, Bechem Martin Dr, Gross Rainer Prof Dr, Hebisch Siegbert Dr, Huetter Joachim Dr, Rounding Howard Paul Dr, Schramm Matthias Dr: 3-formyl-1,4-dihydropyridines, process for their preparation and their pharmaceutical use.. Bayer, December 16, 1992: EP0518105-A1 (8 worldwide citation)

The present invention relates to 3-formyl-1,4-dihydropyridines of the general formula I in which R represents phenyl which is optionally substituted up to 3 times by identical or different nitro, cyano, halogen, trifluoromethyl, trifluoromethylthio, trifluoromethoxy or difluoromethoxy or by straight ...


10
Brunner Helmut Prof Dr, Haberkorn Axel Dr, Boeshagen Horst Dr, Stoltefuss Juergen Dipl Ing, Kume Toyohiko: Immuno stimulating composition.. Bayer, October 16, 1985: EP0158075-A1 (7 worldwide citation)

The immunostimulating compositions contain compounds of the formula I in which R, R, R, R, X and Y have the stated meanings. The invention also relates to a method of intermediate treatment to control coccidial diseases.